Training Healthcare Providers in Motivational Communication for Promoting Physical Activity and Exercise in Cardiometabolic Health Settings: Do We Know What We Are Doing?

Codie R. Rouleau; Kim L. Lavoie; Simon L. Bacon; Michael Vallis; Kim Corace; Tavis S. Campbell

doi:10.1007/s12170-015-0457-2

Training Healthcare Providers in Motivational Communication for Promoting Physical Activity and Exercise in Cardiometabolic Health Settings: Do We Know What We Are Doing?

Codie R. Rouleau, Kim L. Lavoie, Simon L. Bacon, Michael Vallis, Kim Corace, Tavis S. Campbell

Medicine

Medicine

Résultat de recherche: Review article › examen par les pairs

15 Citations (Scopus)

Résumé

Regular physical activity (PA) is essential for secondary and tertiary prevention of cardiometabolic risk factors and disease, but low adherence to PA recommendations is common. Motivational communication (MC) represents a collection of evidence-based behavior change strategies drawn from motivational interviewing, cognitive-behavioral techniques, and behavior change theories that show promise for promoting PA adherence. However, dissemination of MC strategies in cardiometabolic healthcare settings has been limited by inconsistent reporting of training fidelity in intervention research, making it unclear how to optimally train healthcare providers. We discuss preliminary considerations for training individuals in the use of MC, including: being relatively intensive with more than self-directed learning, covering an array of behavior change strategies, offering ongoing mentorship and support, and being delivered by a skilled trainer who addresses diverse trainee needs. Future work is needed to expand upon these considerations and establish what constitutes competent MC training to impact cardiometabolic health outcomes.

Langue d'origine	English
Journal	Current Cardiovascular Risk Reports
Volume	9
Numéro de publication	6
DOI	https://doi.org/10.1007/s12170-015-0457-2
Statut de publication	Published - juin 1 2015

Note bibliographique

Funding Information:
Kimberly Corace received a grant from Reckitt Benckiser. Corace received honoraria from Reckitt Benckiser, Janssen, and Vertex. Corace received payment for educational presentation/speaker’s fee from Janssen. Kim Lavoie has worked as a consultant for Takeda, Boehringer Ingleheim, AbbVie, Kataka Medical Communication, and Almirall. Lavoie received a grant from AbbVie. Lavoie received payments for an educational presentation/speaker’s fee from Kataka Medical Communication, AbbVie, and Takeda, Novartis, Boehringer Ingelheim and Janssen. Lavoie received consulting fees from Boehringer Ingelheim and Almirall. Codie Rouleau has no relevant disclosures to report. Michael Vallis serves on the advisory board for Novo Nordisk. Vallis has worked as a consultant for Novo Nordisk and AbbVie. Vallis received royalties from John Wiley and Sons and payment for educational presentations/speaker’s fee from AbbVie, Pfizer, Novo Nordisk, AstraZeneca, BD, and Sanofi. Vallis received travel/accommodations expenses covered or reimbursed from Novo Nordisk. Simon Bacon reports personal fees from Kataka Medical Communication and personal fees from Merck, outside the submitted work. Tavis Campbell received payment for consultation and/or educational presentation/speaker’s fee from Kataka Medical Communication, AbbVie, Pfizer and Servier. Campbell serves on an advisory board for Pfizer.

Publisher Copyright:
© 2015, Springer Science+Business Media New York.

ASJC Scopus Subject Areas

Pharmacology
Pharmacology (medical)

Accès au document

10.1007/s12170-015-0457-2

Autres fichiers et liens

Citer

@article{29bf6fa258874c6ba5c01393075c366b,

title = "Training Healthcare Providers in Motivational Communication for Promoting Physical Activity and Exercise in Cardiometabolic Health Settings: Do We Know What We Are Doing?",

abstract = "Regular physical activity (PA) is essential for secondary and tertiary prevention of cardiometabolic risk factors and disease, but low adherence to PA recommendations is common. Motivational communication (MC) represents a collection of evidence-based behavior change strategies drawn from motivational interviewing, cognitive-behavioral techniques, and behavior change theories that show promise for promoting PA adherence. However, dissemination of MC strategies in cardiometabolic healthcare settings has been limited by inconsistent reporting of training fidelity in intervention research, making it unclear how to optimally train healthcare providers. We discuss preliminary considerations for training individuals in the use of MC, including: being relatively intensive with more than self-directed learning, covering an array of behavior change strategies, offering ongoing mentorship and support, and being delivered by a skilled trainer who addresses diverse trainee needs. Future work is needed to expand upon these considerations and establish what constitutes competent MC training to impact cardiometabolic health outcomes.",

author = "Rouleau, {Codie R.} and Lavoie, {Kim L.} and Bacon, {Simon L.} and Michael Vallis and Kim Corace and Campbell, {Tavis S.}",

note = "Funding Information: Kimberly Corace received a grant from Reckitt Benckiser. Corace received honoraria from Reckitt Benckiser, Janssen, and Vertex. Corace received payment for educational presentation/speaker{\textquoteright}s fee from Janssen. Kim Lavoie has worked as a consultant for Takeda, Boehringer Ingleheim, AbbVie, Kataka Medical Communication, and Almirall. Lavoie received a grant from AbbVie. Lavoie received payments for an educational presentation/speaker{\textquoteright}s fee from Kataka Medical Communication, AbbVie, and Takeda, Novartis, Boehringer Ingelheim and Janssen. Lavoie received consulting fees from Boehringer Ingelheim and Almirall. Codie Rouleau has no relevant disclosures to report. Michael Vallis serves on the advisory board for Novo Nordisk. Vallis has worked as a consultant for Novo Nordisk and AbbVie. Vallis received royalties from John Wiley and Sons and payment for educational presentations/speaker{\textquoteright}s fee from AbbVie, Pfizer, Novo Nordisk, AstraZeneca, BD, and Sanofi. Vallis received travel/accommodations expenses covered or reimbursed from Novo Nordisk. Simon Bacon reports personal fees from Kataka Medical Communication and personal fees from Merck, outside the submitted work. Tavis Campbell received payment for consultation and/or educational presentation/speaker{\textquoteright}s fee from Kataka Medical Communication, AbbVie, Pfizer and Servier. Campbell serves on an advisory board for Pfizer. Publisher Copyright: {\textcopyright} 2015, Springer Science+Business Media New York.",

year = "2015",

month = jun,

day = "1",

doi = "10.1007/s12170-015-0457-2",

language = "English",

volume = "9",

journal = "Current Cardiovascular Risk Reports",

issn = "1932-9520",

publisher = "Current Medicine Group",

number = "6",

}

TY - JOUR

T1 - Training Healthcare Providers in Motivational Communication for Promoting Physical Activity and Exercise in Cardiometabolic Health Settings

T2 - Do We Know What We Are Doing?

AU - Rouleau, Codie R.

AU - Lavoie, Kim L.

AU - Bacon, Simon L.

AU - Vallis, Michael

AU - Corace, Kim

AU - Campbell, Tavis S.

N1 - Funding Information: Kimberly Corace received a grant from Reckitt Benckiser. Corace received honoraria from Reckitt Benckiser, Janssen, and Vertex. Corace received payment for educational presentation/speaker’s fee from Janssen. Kim Lavoie has worked as a consultant for Takeda, Boehringer Ingleheim, AbbVie, Kataka Medical Communication, and Almirall. Lavoie received a grant from AbbVie. Lavoie received payments for an educational presentation/speaker’s fee from Kataka Medical Communication, AbbVie, and Takeda, Novartis, Boehringer Ingelheim and Janssen. Lavoie received consulting fees from Boehringer Ingelheim and Almirall. Codie Rouleau has no relevant disclosures to report. Michael Vallis serves on the advisory board for Novo Nordisk. Vallis has worked as a consultant for Novo Nordisk and AbbVie. Vallis received royalties from John Wiley and Sons and payment for educational presentations/speaker’s fee from AbbVie, Pfizer, Novo Nordisk, AstraZeneca, BD, and Sanofi. Vallis received travel/accommodations expenses covered or reimbursed from Novo Nordisk. Simon Bacon reports personal fees from Kataka Medical Communication and personal fees from Merck, outside the submitted work. Tavis Campbell received payment for consultation and/or educational presentation/speaker’s fee from Kataka Medical Communication, AbbVie, Pfizer and Servier. Campbell serves on an advisory board for Pfizer. Publisher Copyright: © 2015, Springer Science+Business Media New York.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Regular physical activity (PA) is essential for secondary and tertiary prevention of cardiometabolic risk factors and disease, but low adherence to PA recommendations is common. Motivational communication (MC) represents a collection of evidence-based behavior change strategies drawn from motivational interviewing, cognitive-behavioral techniques, and behavior change theories that show promise for promoting PA adherence. However, dissemination of MC strategies in cardiometabolic healthcare settings has been limited by inconsistent reporting of training fidelity in intervention research, making it unclear how to optimally train healthcare providers. We discuss preliminary considerations for training individuals in the use of MC, including: being relatively intensive with more than self-directed learning, covering an array of behavior change strategies, offering ongoing mentorship and support, and being delivered by a skilled trainer who addresses diverse trainee needs. Future work is needed to expand upon these considerations and establish what constitutes competent MC training to impact cardiometabolic health outcomes.

AB - Regular physical activity (PA) is essential for secondary and tertiary prevention of cardiometabolic risk factors and disease, but low adherence to PA recommendations is common. Motivational communication (MC) represents a collection of evidence-based behavior change strategies drawn from motivational interviewing, cognitive-behavioral techniques, and behavior change theories that show promise for promoting PA adherence. However, dissemination of MC strategies in cardiometabolic healthcare settings has been limited by inconsistent reporting of training fidelity in intervention research, making it unclear how to optimally train healthcare providers. We discuss preliminary considerations for training individuals in the use of MC, including: being relatively intensive with more than self-directed learning, covering an array of behavior change strategies, offering ongoing mentorship and support, and being delivered by a skilled trainer who addresses diverse trainee needs. Future work is needed to expand upon these considerations and establish what constitutes competent MC training to impact cardiometabolic health outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84928613802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928613802&partnerID=8YFLogxK

U2 - 10.1007/s12170-015-0457-2

DO - 10.1007/s12170-015-0457-2

M3 - Review article

AN - SCOPUS:84928613802

SN - 1932-9520

VL - 9

JO - Current Cardiovascular Risk Reports

JF - Current Cardiovascular Risk Reports

IS - 6

ER -

Training Healthcare Providers in Motivational Communication for Promoting Physical Activity and Exercise in Cardiometabolic Health Settings: Do We Know What We Are Doing?

Résumé

Note bibliographique

ASJC Scopus Subject Areas

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer